---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Decitabine and Cedazuridine - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/decitabineandcedazuridine
version: v1
---

# Decitabine and Cedazuridine - NCI

# Decitabine and Cedazuridine

Placeholder slot

(deh-SY-tuh-been â€¦ SEE-daz-YOOR-ih-deen)

This page contains brief information about decitabine and cedazuridine
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Inqovi

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91a0f80b-f865-4d06-a40d-4d148d99ee71&audience=consumer)

## Use in Cancer

Decitabine and cedazuridine
is approved to treat adults with:

- **[Myelodysplastic syndromes](/Common/PopUps/popDefinition.aspx?id=45266&version=Patient&language=English)** (MDS), including [chronic myelomonocytic leukemia](/Common/PopUps/popDefinition.aspx?id=367436&version=Patient&language=English) (CMML).

Decitabine and cedazuridine
is also being studied in the treatment of other types of
[cancer](/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=English).

Decitabine and cedazuridine is a tablet form of [decitabine](/Common/PopUps/popDefinition.aspx?id=45208&version=Patient&language=English) combined with cedazuridine. For more information about the form of decitabine that is given by infusion, see the Drug Information Summary for [Decitabine](/about-cancer/treatment/drugs/decitabine).

## More About Decitabine and Cedazuridine

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759831) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Decitabine and Cedazuridine](https://medlineplus.gov/druginfo/meds/a620050.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Clinical Trials Accepting Patients

[Find Clinical Trials for Decitabine And Cedazuridine](https://www.cancer.gov/research/participate/clinical-trials/intervention/C115102) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
